Log in

Relevant bibliographies by topics / Hypercholesteremia / Journal articles

To see the other types of publications on this topic, follow the link: Hypercholesteremia.

Journal articles on the topic 'Hypercholesteremia'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Hypercholesteremia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Visavadiya, Nishant P., and A. V. R. L. Narasimhacharya. "AsparagusRoot Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats." Evidence-Based Complementary and Alternative Medicine 6, no. 2 (2009): 219–26. http://dx.doi.org/10.1093/ecam/nem091.

Full text

Abstract:

Hyperlipidemia/hypercholesteremia are major risk factors for atherosclerosis and cardiovascular diseases. Root ofAsparagus racemosus(AR) is widely used in Ayurvedic system of medicine in India and is known for its steroidal saponin content. This study was designed to investigate the hypocholesteremic and antioxidant potential of AR root in both normo- and hypercholesteremic animals. Normal and hypercholesteremic male albino rats were administered with root powder of AR (5 and 10 g% dose levels) along with normal and hypercholesteremic diets, respectively, for a duration of 4 weeks. Plasma and

APA, Harvard, Vancouver, ISO, and other styles

2

Khan, Safi U., and Khurram Nasir. "Hypercholesteremia in Indigenous Population." JACC: Advances 2, no. 3 (2023): 100352. http://dx.doi.org/10.1016/j.jacadv.2023.100352.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nordin, Jenizan, and Ahmad Badruddin Ghazali. "Osteonecrosis of the jaw in patients taking Atorvastatin: Case series." IIUM Journal of Orofacial and Health Sciences 3, no. 2 (2022): 219–22. http://dx.doi.org/10.31436/ijohs.v3i2.73.

Full text

Abstract:

Osteonecrosis of the jawbones commonly seen in patients taking bisphosphonates, denosumab, and several antiangiogenic medications with several oral factors such as tooth extraction or dental infection. Currently, patients taking Simvastatin, a medication commonly used to treat hypercholesteremia, were reported of developing osteonecrosis of the jaw. Thus, it is important that clinicians know about the risk of osteonecrosis for patients taking this hypercholesteremia medication. It is not known if the undesirable effect only occurs with Simvastatin or other types of statin medication. We report

APA, Harvard, Vancouver, ISO, and other styles

4

Kamalova, Aelita A. "Diet Therapy in Children with Hypercholesteremia." Current Pediatrics 19, no. 4 (2020): 309–15. http://dx.doi.org/10.15690/vsp.v19i4.2140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dietrich, Hans H. "Apolipoprotein E in Hypercholesteremia and Beyond." Stroke 38, no. 7 (2007): 2036. http://dx.doi.org/10.1161/strokeaha.107.489856.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

LEWIS, S. "P514 Hypercholesteremia induces baroreceptro reflex dysfunction." European Heart Journal 24, no. 5 (2003): 81. http://dx.doi.org/10.1016/s0195-668x(03)93952-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

NAKAI, TSUGUHIKO. "Familial hypercholesteremia complicated by nephrotic syndrome." Nihon Naika Gakkai Zasshi 79, no. 8 (1990): 1079–80. http://dx.doi.org/10.2169/naika.79.1079.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

HURLEY, D. "Hypercholesteremia induces enhanced circulating inflammatory activity." American Journal of Hypertension 17, no. 5 (2004): S242. http://dx.doi.org/10.1016/j.amjhyper.2004.03.648.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Li, Nan F., Hong M. Wang, Jin Yang, Ling Zhou, Xiao G. Yao, and Jing Hong. "Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population." Applied Physiology, Nutrition, and Metabolism 34, no. 6 (2009): 1032–39. http://dx.doi.org/10.1139/h09-101.

Full text

Abstract:

The prevalence of hyperuricemia is low in Uygurs, who have a high prevalence of cardiovascular risk factors such as hypertension, overweight–obesity, dyslipidemia, hyperglycemia, and insulin resistance (IR). This study sought to investigate the relationships between serum uric acid (UA) and these risk factors in this population. A cross-sectional study was conducted in Uygurs (859 males, 1268 females) aged 20 to 70 years. Demographic data, systolic blood pressure (SBP), diastolic blood pressure (DBP), body mass index (BMI), and fasting and postprandial blood were obtained, and biological measu

APA, Harvard, Vancouver, ISO, and other styles

10

Kawsar, Dr Syeda Masuma, and Dr Amirul Islam Bhuyan. "Outcome of Heart Rate and Blood Pressure of a Patient after Successful Coronary Angioplasty and Stenting." Scholars Journal of Applied Medical Sciences 11, no. 03 (2022): 668–71. http://dx.doi.org/10.36347/sjams.2023.v11i03.031.

Full text

Abstract:

Background: When left main coronary artery stenosis is significant, bypass surgery is the recommended treatment option. An alternate therapy, angioplasty with stenting, has been recommended by the outcomes of many multicenter studies. Objective: In this study our main goal is to evaluate the outcome of Heart Rate and Blood Pressure of a Patient after Successful Coronary Angioplasty and Stenting. Method: This cross-sectional study was carried out at tertiary hospital from January 2021 to January 2022. Where 100 patients stent implantation was carried out both men and women aged 69±8 years (rang

APA, Harvard, Vancouver, ISO, and other styles

11

Alsaidan, Aseel Awad. "Knowledge, attitude, and practice of physicians towards familial hypercholesterolemia in north regions of Saudi Arabia." Journal of the Pakistan Medical Association 74, no. 2 (2024): 327–34. http://dx.doi.org/10.47391/jpma.9436.

Full text

Abstract:

Objectives: To assess knowledge, attitude and practice of physicians regarding familial hypercholesterolemia. Method: The cross-sectional study was conducted from October to December 2022 in Aljouf, Tabouk, Hail and northern border regions of Saudi Arabia after approval from the ethics review committee of Qurayyat Health Affairs. Those included were physicians specialising in familial hypercholesteremia and having experience in family medicine, endocrinology, paediatrics, cardiology, internal medicine and obstetrics and gynaecology. Their knowledge, attitude and practice were assessed using a

APA, Harvard, Vancouver, ISO, and other styles

12

Nichols, E. H., and M. R. Jaff. "Hypercholesteremia, Hypertension, and Antiplatelet Therapy in PAD." MD Conference Express 13, no. 19 (2013): 31. http://dx.doi.org/10.1177/155989771319015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Kumawat, Vinod Bihari, Surendra Kumar Sharma, Uttam Kumar Sharma, and Sudhir Sharma. "Effect of trikatu compound in hypercholesteremia- a clinical study." Environment Conservation Journal 16, no. 1&2 (2015): 57–61. http://dx.doi.org/10.36953/ecj.2015.161209.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Tokura, T. "Changes in Bruch's Membrane in Experimental Hypercholesteremia in Rats." Japanese Journal of Ophthalmology 43, no. 4 (1999): 337–38. http://dx.doi.org/10.1016/s0021-5155(99)00055-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

BARTON, M. "Hypercholesteremia induces cardiac concentric remodeling in the guinea pig." American Journal of Hypertension 17, no. 5 (2004): S165—S166. http://dx.doi.org/10.1016/j.amjhyper.2004.03.434.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Yu, Lianlong, Qianrang Zhu, Yuqian Li, Pengkun Song, and Jian Zhang. "Dietary Branched-Chain Amino Acids (BCAAs) and Risk of Dyslipidemia in a Chinese Population." Nutrients 14, no. 9 (2022): 1824. http://dx.doi.org/10.3390/nu14091824.

Full text

Abstract:

This study aimed to explore the association between dietary BCAAs, blood lipid levels and risk of dyslipidemia. In this case–control study, a total of 9541 subjects with normal blood lipids were included as a control group, and 9792 patients with dyslipidemia were included as a case group. Dietary BCAA intake data were measured using 3-day 24 h meal recalls and household condiment weighing. All samples were from China Nutrition and Health Surveillance (2015). Generalized linear model, logistic regression, and restricted cubic spline (RCS) were used to evaluate the relationship between dietary

APA, Harvard, Vancouver, ISO, and other styles

17

Rafaish, Hadeel Ganai, Wefak Albazi, Muna Hussain Al-Aameli, Tahreer M. Al-Thuwaini, and Goosoon Hadi Jhoni. "The effect of an induced hypercholesteremia on the regulation of the ARC gene expression, Brain Derived Neurotropic Factor (BDNF), Synapsing-1 and neurotransmitter –glutamate in male rats." Journal of Kerbala for Agricultural Sciences 11, no. 2 (2024): 11–29. http://dx.doi.org/10.59658/jkas.v11i2.1842.

Full text

Abstract:

An abnormality of lipid metabolism known as hypercholesteremia, which causes blood cholesterol levels to be abnormally high, is a significant health concern. This research, in light of its association with neurodegenerative disease, is of paramount importance as it aims to elucidate how elevated cholesterol levels impact glutamate levels, BDNF, Synapsin K, and ARC gene expression. Ten male rats were meticulously assigned to a control group and another group that was given a 1% cholesterol supplement for 28 days. Each group received a random assignment of rats to ensure the validity of the resu

APA, Harvard, Vancouver, ISO, and other styles

18

Elbadawi, Ayman, Islam Y. Elgendy, Mohamed Omer, et al. "Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia." American Journal of Medicine 134, no. 8 (2021): 992–1001. http://dx.doi.org/10.1016/j.amjmed.2021.03.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Malone, R., P. O'Connor, M. Hennessy, V. Crowley, and C. Kennedy. "Cardiovascular disease risk modifiers in patients with heterozygous familial hypercholesteremia." Atherosclerosis 379 (August 2023): S119. http://dx.doi.org/10.1016/j.atherosclerosis.2023.06.416.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Abumoawad, Abdelrhman, Hesham Mohamed A. Afify, Mohammed Saleh, et al. "OUTCOMES OF ACUTE ISCHEMIC STROKE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEREMIA." Journal of the American College of Cardiology 81, no. 8 (2023): 1879. http://dx.doi.org/10.1016/s0735-1097(23)02323-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Hussain, Cheragh, Muhammad Asghar Khan, Yasir hayat, Nasir --, and Mahmood ul Hassan. "Frequency Of Hypercholesteremia In Patients Presenting With Acute Coronary Syndrome." Global Pharmaceutical Sciences Review VIII, no. I (2023): 71–77. http://dx.doi.org/10.31703/gpsr.2023(viii-i).11.

Full text

Abstract:

To assess the frequency of hypercholesteremia in patients presenting with acute coronary syndrome. From February 1, 2020, to February 1, 2021, 100 patients who presented with acute coronary syndrome underwent a retrospective study at the cardiology department of the Hayatabad Medical Complex in Peshawar. The diagnosis, lab tests, patient outcomes, and demographic information were gathered and examined. All the data analysis was done by SPSS. According to the findings, 24.0% (or 100/100) of the patients had hypercholesterolemia. The patients with hypercholesterolemia were 58.75 + 9.39 years old

APA, Harvard, Vancouver, ISO, and other styles

22

Nagaraj, Lavanya, and Naveen Kumar Madalageri. "A comparative study of metabolic side effects of risperidone and olanzapine in the treatment of schizophrenia." International Journal of Basic & Clinical Pharmacology 8, no. 11 (2019): 2561. http://dx.doi.org/10.18203/2319-2003.ijbcp20194803.

Full text

Abstract:

ABSTRACTBackground: Schizophrenia is one of most serious chronic psychiatric disorder, which affects about 1% of population. Treatment of schizophrenia comprises of typical antipsychotics and or atypical antipsychotics. Typical antipsychotics like haloperidol have extrapyramidal side effects which limit their use in chronic cases. Atypical antipsychotics though have better treatment response, they have metabolic side effects like hypercholesteremia, hypertriglyceridemia and hyperglycaemia. As there is paucity of data in Indian population the present study has been taken up to compare the metab

APA, Harvard, Vancouver, ISO, and other styles

23

Koo, Hui Chin, Lay Kim Tan, Geok Pei Lim, Chee Cheong Kee, and Mohd Azahadi Omar. "Obesity and Its Association with Undiagnosed Diabetes Mellitus, High Blood Pressure and Hypercholesterolemia in the Malaysian Adult Population: A National Cross-Sectional Study Using NHMS Data." International Journal of Environmental Research and Public Health 20, no. 4 (2023): 3058. http://dx.doi.org/10.3390/ijerph20043058.

Full text

Abstract:

This study aimed to report the prevalence of obesity, classified using Asian cut-off, and its relationships with undiagnosed diabetes mellitus, high blood pressure, and hypercholesteremia. We analyzed the nationally representative data from 14,025 Malaysian adults who participated in the NHMS 2015. The relationship between obesity and undiagnosed diabetes mellitus, high blood pressure, and hypercholesteremia was determined using multivariable logistic regressions, and lifestyle risk factors and sociodemographic characteristics were adjusted. The undiagnosed high blood pressure group showed the

APA, Harvard, Vancouver, ISO, and other styles

24

Adama, D., NE Yisa, S. Adama, et al. "Cardiometabolic Risk Screening of Students Attending School of Health Technology, Minna, Niger State, Nigeria." Journal of Medical Laboratory Science 31, no. 2 (2021): 42–51. https://doi.org/10.5281/zenodo.5033240.

Full text

Abstract:

<strong>ABSTRACT</strong> <strong>Aim: </strong>The present study reveals the cardiometabolic risk factor among students of Health Technology Minna Niger State. The purpose of the study is to screen for the cardiometabolic risk factors among students of the institution to determine the prevalence rate. Prevalence of cardiometabolic risk factor was determined on 100 randomly selected students (47 males and 53 females). Method: The study used standard methods for all factors that were examined. Blood samples were collected from the subjects, stored and subsequently, tests were conducted. Other r

APA, Harvard, Vancouver, ISO, and other styles

25

Didia, S. Claudia. "PCSK9-Inhibitors: A Review of a Novel Approach in Hypercholesteremia Management." Medical Science Review 1 (2014): 1–6. http://dx.doi.org/10.12659/msrev.890836.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Saotome, Masao, and Yuichiro Maekawa. "A Japanese Woman with Polygenic Familial Hypercholesteremia Who Exhibited Trivial Atherosclerosis." Internal Medicine 63, no. 15 (2024): 2111–12. http://dx.doi.org/10.2169/internalmedicine.3089-23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Verma, Isha, Antonio Fernandez, and Paul Thompson. "FAMILIAL HYPERCHOLESTEREMIA: WHEN STATINS, EZETIMIBE & PCSK9 INHIBITORS ARE NOT ENOUGH." Journal of the American College of Cardiology 71, no. 11 (2018): A2439. http://dx.doi.org/10.1016/s0735-1097(18)32980-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Verma, Isha, Paul D. Thompson, and Antonio B. Fernandez. "Familial Hypercholesteremia: When Statins, Ezetimibe & PCSK9 Inhibitors Are Not Enough." Journal of Clinical Lipidology 12, no. 2 (2018): 545. http://dx.doi.org/10.1016/j.jacl.2018.03.043.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Valentine, V. G., L. Seoane, D. M. Fuchs, S. G. LaPlace, G. A. Lombard, and D. E. Taylor. "Potential benefits of treating hypercholesteremia and hypertension in lung allograft recipients." Journal of Heart and Lung Transplantation 24, no. 2 (2005): S170. http://dx.doi.org/10.1016/j.healun.2004.12.105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

MUNDAY, J. "Hypercholesteremia-induced changes in left ventricular geometry in the guinea pig." American Journal of Hypertension 17, no. 5 (2004): S168. http://dx.doi.org/10.1016/j.amjhyper.2004.03.441.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Fan, Jing, Caicui Ding, Weiyan Gong, et al. "The Relationship between Leisure-Time Sedentary Behaviors and Metabolic Risks in Middle-Aged Chinese Women." International Journal of Environmental Research and Public Health 17, no. 19 (2020): 7171. http://dx.doi.org/10.3390/ijerph17197171.

Full text

Abstract:

The prevalence of metabolic diseases has increased over the past few decades, and epidemiological studies suggest that metabolic diseases may be associated with lifestyle. The purpose of the present study was to investigate the relationship between leisure-time sedentary behaviors (LTSBs) and metabolic risks in middle-aged women in China. Data came from the China National Nutrition and Health Surveillance (CNNHS) in 2010–2012. A total of 2643 women aged 46 to 53 years were involved. Multiple linear regression was used to examine the association of leisure-time sedentary duration (LTSD) with to

APA, Harvard, Vancouver, ISO, and other styles

32

Zhang, Haoqiang, Rong Huang, Sai Tian, et al. "The CC Genotype of Insulin-Induced Gene 2 rs7566605 Is a Protective Factor of Hypercholesteremia Susceptible to Mild Cognitive Impairment, Especially to the Executive Function of Patients with Type 2 Diabetes Mellitus." BioMed Research International 2020 (June 10, 2020): 1–7. http://dx.doi.org/10.1155/2020/4935831.

Full text

Abstract:

Backgrounds and Aims. Insulin-induced gene 2 (INSIG-2) is closely related to hypercholesteremia, which is a well-recognized risk factor of mild cognitive impairment (MCI) in type 2 diabetes mellitus (T2DM). We aim to investigate the association between promoter of the INSIG-2 rs7566605 single-nucleotide polymorphism (SNP) and T2DM with MCI. Methods. 233 T2DM patients with MCI or without MCI were recruited. Baseline data and genotype frequency were compared between MCI and non-MCI groups. Demographic parameters and neuropsychological tests results were analyzed among patients with different gen

APA, Harvard, Vancouver, ISO, and other styles

33

Al-Zarrad, D., K. Yeung, N. Arebi, L. Dyall, and N. Kamperidis. "P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)." Journal of Crohn's and Colitis 18, Supplement_1 (2024): i1350. http://dx.doi.org/10.1093/ecco-jcc/jjad212.0848.

Full text

Abstract:

Abstract Background Janus kinase inhibitors (JAKi) are the first orally administered treatment for Ulcerative Colitis (UC). The JAK family comprises of four intracellular tyrosine kinases inhibitors (JAK1, JAK2, JAK3 and Tyrosine Kinase 2). Inhibition of the JAK kinases lead to dampening of the inflammatory cytokines which drive Inflammatory Bowel Disease (IBD). Tofacitinib was the first generation pan-JAKi. This was followed by second generation JAKi: Filgotinib and Upadacinib which preferentially inhibit JAK1. We report on the real-world evidence on the efficacy and safety of JAKi in the tre

APA, Harvard, Vancouver, ISO, and other styles

34

Jha, Niharika, and Vanya Narayan. "Multiple giant tuberous xanthomas with type IIa hypercholesteremia in a young male." Indian Journal of Dermatopathology and Diagnostic Dermatology 7, no. 1 (2020): 38. http://dx.doi.org/10.4103/ijdpdd.ijdpdd_40_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Miyayama, Takeshi, Shin-ichiro Miura, Tomo Komaki, et al. "Acute Myocardial Infarction in a 26-Year-Old Patient With Familial Hypercholesteremia." Journal of Clinical Medicine Research 8, no. 7 (2016): 562–65. http://dx.doi.org/10.14740/jocmr2596w.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Yakimenko, O., and Ie Maznichenko. "COMPLEX HYPOLIPIDEMIC THERAPY OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND FAMILIAL HYPERCHOLESTEREMIA." Bulletin of Problems Biology and Medicine 1, no. 2 (2019): 207. http://dx.doi.org/10.29254/2077-4214-2019-1-2-149-207-211.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Hyvärinen, Lea. "FLUORESCENCE CINEANGIOGRAPHIC AND HISTOLOGICAL STUDIES ON THE RABBIT EYE DURING EXPERIMENTAL HYPERCHOLESTEREMIA." Acta Ophthalmologica 46, no. 1 (2009): 57–70. http://dx.doi.org/10.1111/j.1755-3768.1968.tb02495.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Harper, Claudia, Radhika Seimon, Brendon Yee, Amanda Sainsbury, and Elizabeth Cayanan. "Translating Evidence into Practice: A Case Study of Extended Use of a Very Low Energy Diet for Treatment of Co-Morbid Obesity and Chronic Disease." Recent Progress in Nutrition 2, no. 2 (2022): 1. http://dx.doi.org/10.21926/rpn.2202015.

Full text

Abstract:

We report the case of a 30-year-old male with significant obesity (body mass index 47 kg/m2) with co-existing moderate obstructive sleep apnoea, hypertension, hypercholesteremia and hypogonadotropic hypogonadism, who was treated with a very-low-energy diet (VLED) and lifestyle modification programme for 12 months. The patient lost weight throughout the entire treatment period (average weight loss was 2.1 kg/week, for a total of 42.7 kg), and showed marked improvement in co-morbidities and no adverse effects. This case demonstrates that prolonged (5-month) use of a VLED, under close medical sup

APA, Harvard, Vancouver, ISO, and other styles

39

Barrios, Vivencio, and Carlos Escobar. "Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk." Expert Review of Clinical Pharmacology 14, no. 7 (2021): 793–806. http://dx.doi.org/10.1080/17512433.2021.1925539.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Godal, H. C., J. C. Lund, and E. Sivertssen. "LIPIDS AND LIPOPROTEINS IN SERUM IN CASES OF FAMILIAL ESSENTIAL HYPERCHOLESTEREMIA AND XANTHOMATOSIS." Acta Medica Scandinavica 156, S319 (2009): 125–34. http://dx.doi.org/10.1111/j.0954-6820.1956.tb06306.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Pereira, Edmundo Luís Rodrigues, Guilherme Alves da Silva, Marília da Silva Duarte, et al. "Systematic review on the relationship between HIV, Antiretroviral Therapy (ART), hyperglycemia and hypercholesteremia." International Journal of Advanced Engineering Research and Science 12, no. 4 (2025): 41–43. https://doi.org/10.22161/ijaers.124.5.

Full text

Abstract:

HIV (Human Immunodeficiency Virus) infection continues to be a global public health concern, with millions of people living with the virus around the world, largely due to advances in Antiretroviral Therapy (ART) associated with ostensible prevention campaigns. However, if on the one hand a significant increase in the survival of patients with HIV is observed with the use of ART, on the other hand several studies warn of the adverse effects of prolonged use of ART on the metabolic system, particularly in the induction of a persistent hyperglycemic and hypercholesterolemic state, disorders that

APA, Harvard, Vancouver, ISO, and other styles

42

Li, Zhi-Zhao, Qiong Huang, Xiao-li Yang, et al. "Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia." Disease Markers 2022 (April 21, 2022): 1–9. http://dx.doi.org/10.1155/2022/2008556.

Full text

Abstract:

The cholesterol metabolism in humans can be indirectly reflected by measuring cholesterol metabolism marker levels. We aimed to investigate the association of cholesterol homeostasis markers on standard lipid profiling components in familial hypercholesteremia and hyperlipidemia patients. A total of 69 hyperlipidemia patients, 25 familial hypercholesteremia (FHC) patients, and 64 healthy controls were enrolled in this study. We performed routine testing of blood lipid water. Gas chromatography was used to determine the changes in the concentration of cholesterol synthesis (squalene, desmostero

APA, Harvard, Vancouver, ISO, and other styles

43

RANA, MOHAMMAD MOHSIN, BADAR BASHIR, MUHAMMAD SAEED AKHTAR, and Abaid Ur-Rehman. "TYPE 2 DIABETICS." Professional Medical Journal 14, no. 02 (2007): 337–43. http://dx.doi.org/10.29309/tpmj/2007.14.02.4900.

Full text

Abstract:

Objective: To find the relationship between the serum cholesterol andtriglyceroid in type 2 diabetics with different parameters of obesity. Design: Descriptive study. Setting: Al-ShifaMetabolic Center Faisalabad. Period: From January 2003 to June 2005. Material and methods: A total of 2034patients, who fulfill the inclusion criteria were included in this study. Out of these patients 1188 females and 846 males,patients presented to the metabolic center for lipids screening. Body parameters i.e. weight, height, waist and hipcircumference and blood pressure. BMI and WHR were calculated as per sta

APA, Harvard, Vancouver, ISO, and other styles

44

Termos S, Alrashidi M, Alrushaidan S, et al. "Strawberry Gallbladder: A Distinctive Type of Cholesterolosis, Case Report and Literature Review." Annals of Medical and Clinical Case Reports 01, no. 01 (2024): 01–05. http://dx.doi.org/10.70374/amccr.2024.1102.

Full text

Abstract:

Strawberry gallbladder is a benign medical condition that refers to the surface appearance of the gallbladder mucosa. It occurs due to precipitations of lipids and macrophages in the lamina propria of the gallbladder wall. We report the case of a 44-year-old female patient who presented to the emergency department with few days history of biliary colic. Investigations showed elevated AST, ALT and hypercholesteremia. Ultrasound abdomen demonstrated a mild fatty liver and multiple GB polyps. Laparoscopic cholecystectomy was performed. Histopathologic features were consistent with diffuse cholest

APA, Harvard, Vancouver, ISO, and other styles

45

Yuefeng, Yu, Lin Zhiqi, Chen Yi, et al. "Testosterone Deficiency Promotes Hypercholesteremia and Attenuates Cholesterol Liver Uptake via AR/PCSK9/LDLR Pathways." International Journal of Endocrinology 2022 (May 13, 2022): 1–10. http://dx.doi.org/10.1155/2022/7989751.

Full text

Abstract:

Background. Testosterone deficiency is reportedly correlated with an elevation of cholesterol in plasma, but the mechanism remains unclear. Our objective was to investigate the effects of testosterone deficiency on cholesterol metabolism and the corresponding molecular changes in vivo and in vitro. Methods. SD rats were randomized into three groups: sham-operated (SHAM), subtotal orchiectomized (SO), and orchiectomized (ORX) and fed for 8 weeks. HepG2 cells were cultured with medium containing testosterone with the final concentrations of 0, 10, 30, and 300 nM. Method of isotope tracing and fl

APA, Harvard, Vancouver, ISO, and other styles

46

Al-Baldawi, Z., L. Brown, I. Ruel, et al. "SEX DIFFERENCES IN THE PRESENTATION, TREATMENT AND OUTCOMES OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEREMIA." Canadian Journal of Cardiology 39, no. 10 (2023): S232. http://dx.doi.org/10.1016/j.cjca.2023.06.355.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Al-Baldawi, Z., L. Brown, I. Ruel, et al. "SEX DIFFERENCES IN THE PRESENTATION, TREATMENT AND OUTCOMES OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEREMIA." Canadian Journal of Diabetes 47, no. 7 (2023): S193. http://dx.doi.org/10.1016/j.jcjd.2023.10.358.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Drew-Nord, Dana C., OiSaeng Hong, Erika S. Froelicher, Phyllis Berryman, and Eileen Lukes. "Cardiovascular Risk Factors among Career Firefighters." AAOHN Journal 57, no. 10 (2009): 415–24. http://dx.doi.org/10.1177/216507990905701004.

Full text

Abstract:

Sudden cardiac death is the leading cause of on-duty death among firefighters. Determining firefighters' risk of cardiovascular death or all-cause mortality, cardiovascular risk factor profiles, and energy demands while firefighting may aid in understanding why this occupational group is at risk for on-duty sudden cardiac death. A literature review conducted between 2006 and 2009 did not demonstrate that firefighters are at increased risk of all-cause death compared to the general population. In addition, cardiovascular risk profiles of firefighters are similar to those of the general populati

APA, Harvard, Vancouver, ISO, and other styles

49

Mteto Qhayiya, Fihla. "Raising awareness of cardiovascular diseases: A silent killer in South Africa." Journal of Cardiovascular Medicine and Cardiology 11, no. 1 (2024): 013–17. http://dx.doi.org/10.17352/2455-2976.000203.

Full text

Abstract:

Cardiovascular Disease (CVD) is the leading cause of death in Non-Communicable Diseases (NCDs) in the Republic of South Africa (RSA), surpassing all cancers combined. It is estimated that the disease is responsible for 215 deaths daily, with a 17.3% death rate. Common risk factors for the disease include hypertension, diabetes, hypercholesteremia, overweight and obesity, smoking, and stress. Contrary to well-known diseases like HIV/AIDS and TB, CVD does not enjoy enough publicity and attention from the population. This indicates a lack of awareness and concern for the disease among the general

APA, Harvard, Vancouver, ISO, and other styles

50

Proute, Matthew, Tiffany Haynes, Robert Fishberg, and Nosagie Ohonba. "Rethinking Prevention: Need for earlier intervention in Familial Hypercholesteremia despite Statin and PCSK9 Inhibitor Therapy." Journal of Clinical Lipidology 18, no. 4 (2024): e543. http://dx.doi.org/10.1016/j.jacl.2024.04.072.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!